News from all angles
(MedPage Today) -- A U.S. judge rejected Novo Nordisk's request to temporarily block Eli Lilly from running advertisements claiming its weight-loss and diabetes drugs are more powerful. (Reuters via …
Redirecting to MedPage Today in 3 seconds...
Share this story with your network